Page last updated: 2024-10-29

ketoconazole and Tuberous Sclerosis

ketoconazole has been researched along with Tuberous Sclerosis in 1 studies

1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.

Tuberous Sclerosis: Autosomal dominant neurocutaneous syndrome classically characterized by MENTAL RETARDATION; EPILEPSY; and skin lesions (e.g., adenoma sebaceum and hypomelanotic macules). There is, however, considerable heterogeneity in the neurologic manifestations. It is also associated with cortical tuber and HAMARTOMAS formation throughout the body, especially the heart, kidneys, and eyes. Mutations in two loci TSC1 and TSC2 that encode hamartin and tuberin, respectively, are associated with the disease.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Root, AW1
Zamanillo, J1
Duckett, G1
Sweetland, M1

Other Studies

1 other study available for ketoconazole and Tuberous Sclerosis

ArticleYear
Gonadotropin-independent isosexual precocity in a boy with tuberous sclerosis: effect of ketoconazole.
    The Journal of pediatrics, 1986, Volume: 109, Issue:6

    Topics: Age Determination by Skeleton; Child, Preschool; Follicle Stimulating Hormone; Gonadotropins, Pituit

1986